Type 2 & other diabetes

Association between triglyceride-glucose related indices and all-cause and cardiovascular mortality among the population with cardiovascular-kidney-metabolic syndrome stage 0–3: a cohort study

Cardiovasc DiabetolPublished Cohort study

Authors' conclusion

Our study emphasizes the association between TyG and TyG-related indices and mortality in individuals with CKM syndrome stages 0-3. Individuals with CKM syndrome stages 1 and 3 should be more vigilant to abnormal alterations in TyG-related indices.

Study context

Population
Population with cardiovascular-Kidney-Metabolic (CKM) syndrome stage 0–3, National Health and Nutrition Examination Survey (NHANES) 2009–2018
Participants
6,383 participants
Exposure
Triglyceride-glucose (TyG) and TyG-related indices (TyG-waist-to-height ratio (TyG-WHtR), TyG-waist circumference (TyG-WC), TyG-body mass index (TyG-BMI)) in relation to all-cause and cardiovascular mortality
Outcome
All-cause and cardiovascular mortality
Methodological detailsNHANES 2009-2018, survey-weighted
  • NHANES 2009-2018
  • Survey-weighted

Main finding

As reported in the abstract

TyG-WC index and all-cause mortality, HR

1.50 (1.18-1.92) (95% CI)

TyG-WHtR index and all-cause mortality, HR

1.45 (1.13-1.85) (95% CI)

TyG-WHtR index and cardiovascular mortality, HR

1.85 (1.19-2.86) (95% CI)

TyG-WC index and cardiovascular mortality, HR

1.83 (1.21-2.78) (95% CI)

Observational data: associations, not effects.

Further findings

Nonlinear relationship: L-shaped association of TyG-WHtR and TyG-BMI with all-cause mortality

L-shaped association between TyG-WHtR, TyG-BMI and all-cause mortality
both P for log-likelihood ratio < 0.05

Subgroups by CKM syndrome stage: all-cause mortality

TyG-WHtR, TyG-WC and TyG-BMI more pronounced correlation with all-cause mortality in CKM syndrome stages 1 and 3
P < 0.05, P for interaction < 0.05

Original publication

Association between triglyceride-glucose related indices and all-cause and cardiovascular mortality among the population with cardiovascular-kidney-metabolic syndrome stage 0–3: a cohort study. Cardiovasc Diabetol. Published 28 February 2025. doi:10.1186/s12933-025-02642-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.